RESPIRATORY SYNCYTIAL VIRUS (RSV) G AND F ANTIBODIES WITH HIGH RSV-NEUTRALIZING POTENCY
US Application 63/566,064
Filed on 2024-03-15
Filed on 2024-03-15
BROADLY NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS
US Application 63/551,949
Filed on 2024-02-09
Filed on 2024-02-09
Pan-GI norovirus monoclonal antibody 16E10 and its use
US Application 63/653,691
Filed on 2024-05-30
Filed on 2024-05-30
Broadly neutralizing influenza hemagglutinin stem-directed antibodies
US Application 63/605,374
Filed on 2023-12-01
Filed on 2023-12-01
SINGLE-DOMAIN AND BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE
US Application 63/558,539
Filed on 2024-02-27
Filed on 2024-02-27
Broadly Neutralizing Antibodies Against SARS-CoV-2 and SARS-CoV Variants
US Application 63/613,327
Filed on 2023-12-21
Filed on 2023-12-21
Self-assembling Nanoparticles Based On Amphiphilic Peptides
India
202317059300
Filed on 2023-09-04
202317059300
Filed on 2023-09-04
HUMAN MONOCLONAL ANTIBODIES THAT TARGET TERMINAL ALPHA-GAL MOIETIES ON VECTOR-BORNE PATHOGENS AND UNRESECTABLE SOLID TUMORS
US Application 63/647,859
Filed on 2024-05-15
Filed on 2024-05-15
NOVEL COMPOSITIONS OF MATTER COMPRISING PROTEINS THAT INCORPORATE PFS230 DOMAIN 1 (PFS230D1) AT THE N-TERMINUS, MALARIA VACCINE ANTIGENS, AND THEIR USE
US Application 63/617,717
Filed on 2024-01-04
Filed on 2024-01-04